They used clinical guidelines and validated tools in most studies to deliver care and monitor and identify disease-specific changes of the course of disease.
Together, due to many sources influencing lysoPC concentration in blood, which may depend on the individual's genotype and lifestyle, it may be challenging to detect disease-specific changes of lysoPCs in the general population, such as in our recent study in a general population cohort [ 27].
Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia.
HRQL measures potentially provide a holistic measure of the impact of critical illness on the patient, a measure of the contribution of disease-specific changes in health to overall patient well-being, and a means to evaluate the health economic impact of intensive care medicine (e.g. the Quality Adjusted Life Year estimates).
LOAD cells exhibited an impaired mitochondrial metabolic potential and an abnormal redox potential, associated with reduced nicotinamide adenine dinucleotide metabolism and altered citric acid cycle activity, but not with disease-specific changes in mitochondrial mass, production of reactive oxygen species, transmembrane instability, or DNA deletions.
Our observations of disease-specific changes in Vγ9/Vδ2 T cell functions are consistent with the hypothesis that these cells play a role in the pathogenesis of BD.
Our preliminary analysis suggests that performance declines when fewer than 20 subjects are included from each diagnostic group (Kloppel et al., 2008 a ) but the number is likely to depend on the extent and variability of disease-specific changes in brain structure.
This new approach revealed regional and disease-specific changes in synaptic phenotypes, including validation of this method with the expected changes in the molecular composition of striatal dopaminergic synapses in Lewy body disease and Alzheimer's disease.
The AGEP method is a widely applicable method for the rapid comprehensive interpretation of microarray data, as proven here by the definition of tissue- and disease-specific changes in gene expression as well as during cellular differentiation.
A PDE2A PET tracer could enable evaluation of disease-specific changes and testing of candidate compounds.
Owing to its sectional imaging, tomosynthesis shows structures in more detail that cannot be sufficiently evaluated with radiography, such as a superior assessment of mucus plugging and bronchiectases, which according to some authors [16] are the most specific changes of CF lung disease.
